Clinical Trial

Trial of Tirzepatide for the Treatment of Cannabis Use Disorder

Name: Trial of Tirzepatide for the Treatment of Cannabis Use Disorder — clinical trial record (NCT07468552)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this randomized, double-blind, placebo-controlled, multi-site clinical trial is to evaluate the safety and efficacy of tirzepatide in a sample of 100 patients diagnosed with moderate or severe CUD by DSM-5 criteria.

Trial Details

NCT Number	NCT07468552
Lead Sponsor	National Institute on Drug Abuse (NIDA)
Conditions	Cannabis Use Disorder
Enrollment	100 participants
Start Date	2026-11-15
Primary Completion	2028-03-15 (estimated)
Study Completion	2028-11-15 (estimated)
Updated on ClinicalTrials.gov	2026-03-12